๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
NCT06214143Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1/2
68
Anyang, Bengbu, Changsha, Chengdu, Dongwan, Fuzhou, Guangzhou, Hangzhou
2024-01-11
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals, Inc.
Phase 3
410
2024-01-11
Recruiting
The Study on the Accuracy of Peri-implant Probing and Related Influencing Factors
NCT07004517Peri-Implantitis, Diagnosis
The Dental Hospital of Zhejiang University School of Medicine
Observational
83
Hangzhou
2024-01-11
Recruiting
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
NCT06208410Advanced Solid Tumors
Risen (Suzhou) Pharma Tech Co., Ltd.
Phase 1/2
306
Zhengzhou
2024-01-11
Recruiting
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
NCT06157502Ischemic Stroke, Acute
Beijing Tiantan Hospital
Phase 3
1,380
Beijing, Chongqing, Qianjiang, Guangzhou, Heyuan, Maoming, Meizhou, Yunfu
2024-01-11
Recruiting
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
NCT06109272Hepatocellular Carcinoma
AbbVie
Phase 2/3
660
2024-01-11
Recruiting
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
NCT06155396Cervical Cancer
RemeGen Co., Ltd.
Phase 2
116
Bengbu, Beijing, Chongqing, Nanning, Changsha, Nanchang, Shenyang, Jinan
2024-01-11
Active, closed
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naรฏve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
NCT06256328Gastric Cancer
Ono Pharmaceutical Co., Ltd.
Phase 2
226
2024-01-10
Recruiting
A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy
NCT06549907MSS Metastatic Colorectal Cancers, MSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy
Peking University Cancer Hospital & Institute
Observational
50
Beijing
2024-01-10
Recruiting
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
NCT06215950Ovarian Cancer, Cervix Cancer, Metastatic Cancer, Advanced Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
36
Wuhu
2024-01-10
Recruiting
Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian Cancer
NCT07616310Ovarian Cancer (OvCa)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
300
Hangzhou
2024-01-10
Recruiting
A Study of AK131 in Patients With Advanced Solid Tumors
NCT06166888Solid Tumor
Akeso
Phase 1
130
Jinan
2024-01-10
Recruiting
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
NCT06244628cGVHD
Xuzhou Medical University
Phase 3
20
Xuzhou
2024-01-10
Recruiting
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
NCT05941741Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy, Chemotherapy
Sun Yat-sen University
Phase 3
380
Guangzhou, Nanning, Nanchang
2024-01-10
Recruiting
Steroid Diabetes in Patients With Kidney Disease
NCT06161701Nephrotic Syndrome
Zhejiang Provincial People's Hospital
Observational
300
Hangzhou
2024-01-10
Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer
NCT06149689Pancreatic Adenocarcinoma
Fudan University
Phase 2
30
Shanghai
2024-01-10
Recruiting
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
NCT06978439Kawasaki Disease, Pilot Study, Coronary Artery Aneurysm, Rivaroxaban
Children's Hospital of Fudan University
Phase 4
10
Shanghai
2024-01-10
Recruiting
Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3)
NCT06010641Stroke, Acute Ischemic
General Hospital of Shenyang Military Region
Not applicable
600
Shenyang
2024-01-10
Recruiting
SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen
NCT06123494HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
360
Shanghai
2024-01-09
Active, closed
Toripalimab for High-risk Locally Advanced Cervical Cancer
NCT06416696Cervical Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
57
Beijing
2024-01-09
Active, closed
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
NCT06105632Advanced or Metastatic Breast Cancer
Pfizer
Phase 2
333
Wuhan, Changsha, Shanghai
2024-01-09
Active, closed
A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China
NCT05821855Open-angle Glaucoma, OAG
AbbVie
Phase 4
120
Beijing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Wuhan, Qingdao, Chengdu
2024-01-09
Active, closed
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors
NCT06312475Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Suzhou Alphamab Co., Ltd.
Phase 3
53
Tianjin
2024-01-09
Recruiting
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
NCT06278454Unresectable Pancreatic Cancer, Advanced Pancreatic Cancer, Lymph Node Metastases
Chengdu New Radiomedicine Technology Co. LTD.
Phase 1
58
Zhengzhou, Suzhou, Shanghai, Chongqing, Tianjin
2024-01-09
Recruiting
Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism
NCT06238232Primary Aldosteronism
Qifu Li
Not applicable
320
Chongqing
2024-01-09
By invitation
Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.
NCT06649825Familial Adenomatous Polyposis (FAP)
Shanghai Zhongshan Hospital
Not applicable
10
Shanghai
2024-01-08
Active, closed
Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs
NCT07119242NETs
HTA Co., Ltd.
Phase 3
95
Beijing
2024-01-08
Recruiting
The Effect of Oral Gan Shuangbi During the Perinatal Period on the Recovery of Intestinal Function After Cesarean Section in Pregnant Women- A Multicenter, Double-blind, Randomized Controlled Clinical Trial
NCT06347770Microbiota, Postoperative Recovery
Zhe Li
Phase 1
404
Guangzhou
2024-01-08
Recruiting
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413Asthma
AstraZeneca
Observational
355
Chengdu, Beijing, Changsha, Dongguan, Foshan, Guangzhou, Hainan, Hohhot
2024-01-08
Recruiting
Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China
NCT06228196BPPV, Vertigo, Vertigo, Peripheral
First Affiliated Hospital Xi'an Jiaotong University
Observational
150
Xi'an
2024-01-08
Recruiting
Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring
NCT07115459Acute Brain Injury Coma, Neurocritical Care, Cerebral Infarction, Intracranial Hemorrhages
Xiangya Hospital of Central South University
Observational
200
Changsha
2024-01-08
Recruiting
Intervention for Children With Type 1 Diabetes Targeting Gut Microbes
NCT06198725Type 1 Diabetes
Children's Hospital of Fudan University
Not applicable
110
Shanghai
2024-01-08
Recruiting
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
NCT06238713Prostate Adenocarcinoma, Localized Prostate Carcinoma
Shanghai Changzheng Hospital
Not applicable
480
Shanghai
2024-01-08
Recruiting
Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
NCT06211166Acute Leukemia, MDS, MDS/MPN, CML
Peking University People's Hospital
Observational
300
Beijing
2024-01-08
Recruiting
ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery
NCT06204835Hepatocellular Carcinoma
Institute of Automation, Chinese Academy of Sciences
Phase 1
90
Guangzhou, Luzhou
2024-01-07
Recruiting
Magnetic Resonance Imaging Study on Young and Middle-aged Patients With Cervical Spondylotic Pain
NCT06217029Neck Pain
First Affiliated Hospital Xi'an Jiaotong University
Observational
80
Xi'an
2024-01-06
Recruiting
Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial
NCT06091332Cavernous Malformations, Intracerebral Hemorrhage, Brainstem Stroke
Huashan Hospital
Phase 2
75
Shanghai
2024-01-05
Recruiting
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
NCT06192979Amyloidosis; Systemic, AL Amyloidosis
Jin Lu, MD
Not applicable
41
Beijing, Nanjing, Qingdao, Xiโ€™an
2024-01-05
Recruiting
A Study of NWY001 in Subjects With Advanced Solid Tumors
NCT05979155Advanced Solid Tumor
Chipscreen Biosciences, Ltd.
Phase 1
196
Guangzhou
2024-01-05
Recruiting
Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis
NCT06716281Knee Osteoarthritis
Shanghai IxCell Biotechnology Co., LTD
Phase 3
398
Shanghai
2024-01-05
Recruiting
Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis
NCT06230055HER2-negative Breast Cancer, Leptomeningeal Metastasis
Fudan University
Phase 4
37
Shanghai
2024-01-05
Recruiting
Rivaroxaban in Idiopathic Membranous Nephropathy
NCT07404436Idiopathic Membranous Nephropathy
Beijing Friendship Hospital
Phase 4
134
Beijing
2024-01-05
Recruiting
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating ฮฒ-thalassemia Major
NCT06465550ฮฒ-thalassemia
Shanghai BDgene Co., Ltd.
Phase 1
9
Guangzhou, Nanning, Shanghai
2024-01-05
Recruiting
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
NCT06503744Lung Cancer Stage IA
Shanghai Chest Hospital
Not applicable
110
Shanghai
2024-01-04
Recruiting
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
NCT06155032Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
First Affiliated Hospital of Wannan Medical College
Not applicable
272
Fuyang, Hefei, Huainan, Huangshan City, Suzhou, Wuhu, Xiangyang
2024-01-04
Recruiting
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients
NCT06219239Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
3
Tianjin
2024-01-04
Recruiting
CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL
NCT06179524Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic Leukemia
Beijing Yongtai Ruike Biotechnology Company Ltd
Phase 2
100
Tianjin
2024-01-03
Recruiting
Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab
NCT07253896Safety
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
40
Hangzhou
2024-01-03
Recruiting
A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT07256301PNH - Paroxysmal Nocturnal Hemoglobinuria
Shanghai Lanyi Therapeutics Co., Ltd.
Phase 1
24
Tianjin, Hangzhou
2024-01-03
Recruiting
A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors
NCT06374173Advanced or Metastatic Solid Tumors
Hefei TG ImmunoPharma Co., Ltd.
Phase 1
123
Beijing
2024-01-03
Recruiting
A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
NCT06250699Nonfunctional Adrenal Cortex Adenoma, Primary Aldosteronism, Cushing Syndrome
Zhe Meng
Not applicable
200
Wuhan
2024-01-03
Recruiting
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
NCT06111638Hemophilia A
Shanghai Xinzhi BioMed Co., Ltd.
Phase 2/3
55
Beijing, Guangzhou, Guiyang, Wuhan, Changsha, Suzhou, Xiโ€™an, Chengde
2024-01-03
Active, closed
Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa
NCT06079281Hypophosphatasia
Alexion Pharmaceuticals, Inc.
Phase 3
124
Beijing, Changsha, Chengdu, Nanchang, Qingdao, Shanghai, Shenzhen
2024-01-03
Active, closed
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
NCT06056804Locally Advanced Rectal Cancer
Beijing Friendship Hospital
Phase 2
20
Beijing
2024-01-03
Recruiting
Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule
NCT06673121Pulmonary Nodule, Cohort Study, Traditional Chinese Medicine
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine
Observational
5,000
Zhengzhou
2024-01-03
Recruiting
Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors
NCT06950086HR-positive, HER2-negative Advanced Breast Cancer
TYK Medicines, Inc
Phase 1/2
180
Shanghai
2024-01-02
Recruiting
MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients
NCT06197724Non ST Segment Elevation Acute Coronary Syndrome
Qilu Hospital of Shandong University
Observational
14,090
Jinan
2024-01-02
Recruiting
A Study of TYK-00540 in Adult Patients With Solid Tumors
NCT06246071Locally Advanced or Metastatic Solid Tumors
TYK Medicines, Inc
Phase 1
156
Hefei
2024-01-02
Recruiting
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
NCT06217185HER2-positive Breast Cancer, Advanced Breast Cancer
Hebei Medical University Fourth Hospital
Phase 4
100
Shijiazhuang
2024-01-02
Recruiting
Neuromodulation and Attention Deficits in MDD
NCT07111169Major Depression Disorder, Cognitive Deficits, Selective Attention
University of Electronic Science and Technology of China
Not applicable
60
Chengdu
2024-01-01
Recruiting
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis
NCT06542640Psychosis; Schizophrenia-Like, Healthy Controls
Beth Israel Deaconess Medical Center
Not applicable
300
Shanghai
2024-01-01
By invitation
Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
NCT05788029Periampullary Adenocarcinoma
Tongji Hospital
Not applicable
212
Wuhan
2024-01-01
By invitation
An Early Warning Model of Unfavorable Outcomes Following Endovascular Interventional Treatment of Intracranial Aneurysm
NCT06364293Intracranial Aneurysm
Beijing Tiantan Hospital
Observational
750
Beijing
2024-01-01
Recruiting
Exosome microRNAs as Potential Biomarkers of Metabolic Bone Disease of Prematurity
NCT06368154Exosomes, Newborn, Bone Diseases, Metabolic
Hunan Children's Hospital
Observational
200
Changsha
2024-01-01
Recruiting
Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy
NCT05965531Rectal Cancer
Sun Yat-sen University
Phase 2
65
Guangzhou
2024-01-01
Recruiting
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262Breast Cancer, MRD
The First Hospital of Jilin University
Observational
40
Changchun
2024-01-01
Not yet open
RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy
NCT06012214Surgical Procedure, Unspecified
Shanghai Chest Hospital
Not applicable
300
Shanghai
2024-01-01
Recruiting
Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
NCT06541626Multiple Sclerosis, MS, Neuromyelitis Optica Spectrum Disorders, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Acute Disseminated Encephalomyelitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
450
Guangzhou
2024-01-01
Recruiting
Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model
NCT06202404Metastasis, Predictive Cancer Model
Fudan University
Observational
166
Shanghai
2024-01-01
Recruiting
RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
NCT07065435HER2 + Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
74
Nanjing
2024-01-01
Recruiting
MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT
NCT06748690Gastrointestinal Stromal Tumor of Stomach, Submucosal Tumor of Stomach
Peking University People's Hospital
Not applicable
96
Beijing
2024-01-01
Recruiting
The Study of Differences in Eosinophil Function and Subsets in Patients With Eosinophilic Pulmonary Diseases
NCT06944418Eosinophil Subtype, Eosinophilic Pulmonary Diseases
Peking Union Medical College Hospital
Observational
300
Beijing
2024-01-01
Recruiting
Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study
NCT07724496Helicobacter Pylori, Early Gastric Cancer
Chinese PLA General Hospital
Observational
1,500
Beijing
2024-01-01
Active, closed
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML
NCT07437170Acute Myeloid Leukemia, Pediatric Acute Myeloid Leukemia, NUP98 Fusion-positive Acute Myeloid Leukemia
The Children's Hospital of Zhejiang University School of Medicine
Phase 2
10
Hangzhou
2024-01-01
Active, closed
Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis
NCT06596941Iddvt, Pulmonary Embolism (PE)
Ruijin Hospital
Observational
800
Shanghai
2024-01-01
Recruiting
Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis
NCT07622212Deep Vein Thrombosis
RenJi Hospital
Observational
180
Shanghai
2024-01-01
Recruiting
A Pilot Study of the Effect of the Combination of Inhaled Nitric Oxide and Prone Position Under EIT Monitoring on Efficacy in Patients with ARDS
NCT06741137ARDS
Northern Jiangsu People's Hospital
Not applicable
30
Yangzhou
2024-01-01
Recruiting
A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion
NCT07422506Missed Abortion, Early Pregnancy Failure
The Third Xiangya Hospital of Central South University
Not applicable
580
Changsha
2024-01-01
Not yet open
A Novel Approach Integrating Magnetic Resonance Imaging (MRI) Data and Artificial Intelligence for Predicting the Success Rate of Vaginal Delivery in Pregnant Women
NCT06044129Vaginal Delivery
Second Affiliated Hospital of Wenzhou Medical University
Observational
200
Wenzhou
2024-01-01
Active, closed
Arresting Early Childhood Caries With a Silver Diamine Fluoride Gel
NCT06241261Early Childhood Caries
The University of Hong Kong
Phase 2
630
Hong Kong
2024-01-01
Active, closed
Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer
NCT06215677Colon Cancer, Mismatch Repair Deficiency, Immunotherapy
Peking Union Medical College Hospital
Phase 2
18
Beijing
2024-01-01
Recruiting
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
NCT06254690Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
102
Nanjing
2024-01-01
By invitation
To Observe the Clinical Efficacy of Traditional Chinese Medicine Compound(Weipi Formula ) in the Treatment of Epigastric Stuffiness Syndrome
NCT06985524Functional Dyspepsia(FD) Was Studied
Second Affiliated Hospital of Nanchang University
Not applicable
256
Nanchang
2024-01-01
Recruiting
Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
NCT07037680Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety
JIANYANG WANG
Phase 2
44
Beijing
2024-01-01
Not yet open
China National Study of Adrenal Venous Sampling
NCT06192238Hyperaldosteronism
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,500
Beijing, Chongqing, Xiamen, Lanzhou, Foshan, Guangzhou, Shenzhen, Nanning
2024-01-01
Recruiting
Effect of Human Urinary Kallidinogenase on Inflammatory Factors in Acute Ischemic Stroke (KIF-AIS)
NCT06696703Acute Ischemic Stroke
First Affiliated Hospital of Harbin Medical University
Not applicable
200
Harbin
2024-01-01
By invitation
18F-MFBG Cardiac Imaging for Heart Failure Administration
NCT06149195Rest Gated Myocardial Perfusion Imaging in Heart Failure
Sichuan Provincial People's Hospital
Observational
100
Chengdu
2024-01-01
Active, closed
Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT06547944Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
30
Tianjin
2024-01-01
Not yet open
Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer
NCT06166589Previously AG Chemotherapy Treated Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 2
19
Shanghai
2024-01-01
Recruiting
Interferon-ฮฑ for TP53 Myeloid Malignancy Post Allo-HSCT
NCT06130579Myeloid Leukemia, Myelodysplastic Syndromes
Peking University People's Hospital
Phase 2
35
Beijing
2024-01-01
Recruiting
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
NCT06232694Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University
Not applicable
54
Nanjing
2024-01-01
By invitation
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
NCT06959784Diabetes Mellitus, Cardiovascular Diseases, Cerebrovascular Disease
China-Japan Friendship Hospital
Phase 4
142
Beijing
2024-01-01
Recruiting
Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models
NCT06848959Cerebral Palsy, Mental Retardation, Tourette's Syndrome, Attention Deficit Hyperactivity Disorder
Yun Liu,PhD
Observational
2,000
Nanjing
2024-01-01
Recruiting
To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants
NCT07490587Healthy Children
Min-Tze LIONG
Phase 2
366
Pudong
2024-01-01
Recruiting
Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
NCT07446452HER2-low Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
37
Nanjing
2024-01-01
Recruiting
Development and Application of a Clinical Decision Support System for Exercise Rehabilitation in Patients With Osteoporotic Vertebral Compression Fractures
NCT07623304Clinical Decision Support System
Jiawei Jiang
Not applicable
60
Nantong
2024-01-01
Not yet open
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
NCT06095167Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 3
476
Fuzhou
2024-01-01
Recruiting
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
NCT06775977Bladder Cancer, Staging, Contrast Enhanced Ultrasound
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
480
Guangzhou
2024-01-01
Recruiting
Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer
NCT06249750Metastatic Castration-resistant Prostate Cancer (CRPC)
Pengyuan Liu
Phase 2
60
Hangzhou
2024-01-01
Recruiting
Electro-acupuncture to Treat Disorder of Consciousness
NCT06268236Disorder of Consciousness, Electroacupuncture
The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Not applicable
50
Guangzhou
2024-01-01
Rows per page Showing 13801–13900 of 19052
Previous 137 138 139 140 141 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=139

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.